When was this interview? Cam guided to a 100K RUN-RATE by year-end (not 100K treatments by then) --- that was back in the summer. "On track" means they could still hit that number if they ramped production back up based on approval. Longs should be praying HGEN isn't producing to 100K treatments unless of course you believe massive dilution doesn't matter.
What are you talking about? Nobody said anything about Dale's shares not being in the outstanding share count. The share count has increased and continues to do so, as the Company continues selling shares every chance they get to very smart shareholders who think dilution doesn't matter.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.